Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-09-12

Clinical Trial Update: Effects of Aripiprazole and Haloperidol on Mesolimbic System Functioning [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial has completed evaluating the effects of aripiprazole and haloperidol on mesolimbic system functioning in patients with psychosis and sc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Abilify (aripiprazole)
  • Haldol (haloperidol)

Snippet

Sponsor: Oslo University Hospital | Conditions: Psychosis, Schizophrenia | Phase 4 | Status: COMPLETED